ESR1 and breast cancer: Currently, the mechanisms of endocrine therapy resistance in breast cancer have been found to include estrogen receptor gene abnormalities (4), deregulated activation of cell signaling pathways (5), epigenetic regulation (6), alteration of cell cycle regulation (7), and the existence of tumor stem cell-like cells (8).